RT Journal Article
SR Electronic
T1 Postmarketing adverse drug reactions
JF Neurology: Clinical Practice
FD Lippincott Williams & Wilkins
SP 288
OP 294
DO 10.1212/CPJ.0b013e3182a1b9f0
VO 3
IS 4
A1 Klein, Eran
A1 Bourdette, Dennis
YR 2013
UL http://cp.neurology.org/content/3/4/288.abstract
AB Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.